Idorsia

Idorsia AG
Company typePublic company
ISINCH0363463438
Industry
Founded2017
FounderJean-Paul Clozel, Martine Clozel
HeadquartersAllschwil,
Switzerland
Key people
Jean-Paul Clozel (CEO), Martine Clozel (Chief Scientific Officer), Guy Braunstein (Chief Medical Officer)
Productsclazosentan, daridorexant
Revenue- 828 million CHF (2023)
Number of employees
> 1200 (2022)
Websitehttp://www.idorsia.ch; http://www.idorsia.com

Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.